Pharmacologic treatment of hypertension in patients with chronic kidney disease.

Link to article at PubMed

Related Articles

Pharmacologic treatment of hypertension in patients with chronic kidney disease.

Am J Cardiovasc Drugs. 2013 Jun;13(3):177-88

Authors: Talreja H, Ruzicka M, McCormick BB

Abstract
Hypertension remains an important cause of morbidity and mortality in patients with chronic kidney disease. It both contributes to and is a consequence of chronic renal dysfunction. There is a high prevalence of hypertension in chronic kidney disease, and rates of control remain sub-optimal. Numerous studies have highlighted the benefit of treating hypertension in reducing the overall mortality as well as progression of renal disease in this population. Non-pharmacologic treatment strategies remain the primary intervention in all patients but are insufficient on their own to control hypertension in most cases. Pharmacologic treatment recommendations, however, vary depending on the specific etiology of disease as well as patient characteristics. Though most classes of anti-hypertensive drugs can be used to lower blood pressure in chronic kidney disease, therapy needs to be selected based on the presence of specific co-morbidities as well as the etiology of the kidney disease. Most patients will require multi-drug therapy for achieving target blood pressure goals. This review discusses the pharmacologic options in management of hypertension in various forms of chronic kidney disease.

PMID: 23553321 [PubMed - indexed for MEDLINE]

Leave a Reply

Your email address will not be published. Required fields are marked *